chrisvoncsefalvay/vaers-outcomes huggingface dataset:
he tested postiive 18May2022; he tested postiive 18May2022; This is a spontaneous report received from a non-contactable reporter(s) (Nurse).  A 58-year-old male patient received BNT162b2 (BNT162B2), on 27Jan2021 as dose 1, single (Lot number: EL3247), on 17Feb2021 as dose 2, single (Lot number: EL3247) and on 26Oct2021 as dose 3 (booster), single (Lot number: FF2589) at the age of 58 years for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset 18May2022, outcome "unknown" and all described as "he tested postive 18May2022". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (18May2022) Positive, notes: COVID-test type post vaccination: Nasal Swab. It was unknown if therapeutic measures were taken as a result of vaccination failure, covid-19.  Clinical course information: The patient had mild allergy on 15May2022 and on 16May2022 his daughter exposed at school and tested positive 17May2022 and he tested positive on 18May2022.  No follow-up attempts are possible. No further information is expected.; Sender's Comments: Based on the information provided, known drug safety profile and plausible temporal association, the causality between BNT162B2 and the events vaccination failure and Covid 19  cannot be completely excluded.
down and out; couldn't wake up for a while; sleepy; nausea; did not feel right; felt cold; felt weak; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (did not feel right), NASOPHARYNGITIS (felt cold), ASTHENIA (felt weak), FEELING ABNORMAL (down and out) and ASTHENIA (couldn't wake up for a while) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 046A21A and 031M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 19-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Mar-2021, the patient experienced FEELING ABNORMAL (did not feel right), NASOPHARYNGITIS (felt cold) and ASTHENIA (felt weak). On an unknown date, the patient experienced FEELING ABNORMAL (down and out), ASTHENIA (couldn't wake up for a while), SOMNOLENCE (sleepy) and NAUSEA (nausea). At the time of the report, FEELING ABNORMAL (did not feel right), NASOPHARYNGITIS (felt cold), ASTHENIA (felt weak), FEELING ABNORMAL (down and out), ASTHENIA (couldn't wake up for a while), SOMNOLENCE (sleepy) and NAUSEA (nausea) outcome was unknown.            No concomitant was provided. Patient treatment information was not provided.
Five minutes after receiving RabAvert vaccine, pt. felt light-headed and was pale. EMTs at the fire station checked the pt. BP was 88/50. Blood sugar was 103. Pt. had eaten breakfast about 4 hours before injection, and had been working outside in the very warm weather without drinking any water. After approximately a half hour, BP was normal and pt. was able to walk out of the building. He stated that he was feeling better.
symptoms of covid = cough, fever, chills, headache, SOB, not hypoxic. tested positive for covid on 1/4
Doses administered after more than 1 temperature excursion; dose administered to patient after more than 1 temperature excursion/vial stored at cooler storage during high-pace COVID-19 vaccination clinic at the time of the excursion; This spontaneous case was reported by an other health care professional and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (dose administered to patient after more than 1 temperature excursion/vial stored at cooler storage during high-pace COVID-19 vaccination clinic at the time of the excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion) in an 88-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 019B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 27-Mar-2021 at 3:14 PM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 27-Mar-2021 at 3:14 PM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (dose administered to patient after more than 1 temperature excursion/vial stored at cooler storage during high-pace COVID-19 vaccination clinic at the time of the excursion). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (dose administered to patient after more than 1 temperature excursion/vial stored at cooler storage during high-pace COVID-19 vaccination clinic at the time of the excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion) outcome was unknown.      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant products were not provided.  On 27-Mar-2021, Excursion time was 09 AM and 10 AM, temperature was 35, total doses given for the day was 195, condition of vaccine prior to administration was not frozen, vaccine was moved to fridge on 23-Mar-2021, vial was moved to clinic on 27-Mar-2021. 20 vials were sent to clinic. Vaccine BUD date was 22-Apr-2021.  The vials were only punctured right before administration and all doses were drawn from the vial due to high-pace clinic.  It was reported that the patient was administered with vaccines that experienced more than 1 temperature excursion during 33 weeks on 2021. The HCP explained that each time a vial was put into a cooler, there was a period of time of 1 hour or 1 hour and a half approximately, when the temperature data logger registered 34 or 35 degree F.  Temperature recordings were taken using a temperature monitor at every hour. After administration, the vial was returned to the freezer/refrigerator, or maintained at room temperature.  Treatment medications were not reported.   This case was linked to MOD-2022-566976 (Patient Link).
Screamed and grunted in pain for 11 hours straight from body aches, high fever, severe chills, confusion, inability to function, vertigo, loss of consciousness, throat so sore it felt like fire, couldn't swallow, couldn't get comfortable, nearly died. These side effects ARE NOT MINOR. You guys minamalize these side effects. Shameful!!
PATIENT NOTICED SYMPTOMS AROUND 7-8PM DURING THE EVENING TIME.  SHE EXPERIENCED REDNESS,SWELLING,SORE ARM, AND FEELING HOT AT THE INJECTION SITE.
Bad taste in mouth ongoing: sour/bitter/metallic  I have no conditions that would normally cause this. I stated getting this about 1 month after the shot. It has been more or less since then. I believe it is an uncommon but documented side effect, and I wanted to make sure I reported it for your records.
approx 11days p/vax pt presented w/swollen arm (rt)/pink & tender few scattered papular RUE & trunk;
allergic reaction to an allergy shot; This spontaneous case was reported by a consumer and describes the occurrence of HYPERSENSITIVITY (allergic reaction to an allergy shot) in a 33-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced HYPERSENSITIVITY (allergic reaction to an allergy shot). The patient was treated with METHYLPREDNISOLONE SODIUM SUCCINATE (SOLUMEDROL) ongoing from 16-Mar-2021 for Adverse event, at a dose of 125 mg. At the time of the report, HYPERSENSITIVITY (allergic reaction to an allergy shot) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Concomitant medications were not provided.   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 06-May-2021: Telephone Contact Report (TCR) Called and consumer said she don't need a follow-up, she is doing fine.
normal reactions but no out of ordinary reaction.; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (normal reactions but no out of ordinary reaction.) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (normal reactions but no out of ordinary reaction.). At the time of the report, VACCINATION COMPLICATION (normal reactions but no out of ordinary reaction.) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       No concomitant and treatment medication was reported.   This case was linked to MOD-2022-488543 (Patient Link).   Reporter did not allow further contact
This spontaneous report was received from the office manager and refers to multiple unknown number of patients of unknown age and gender. The patients' medical history, concurrent conditions and concomitant medication were not reported. On an unknown date, the patients were vaccinated with improperly stored doses of GARDASIL 9 lot # L043213, expiration date 28-AUG-2017; lot # L048459, expiration date 22-FEB-2018; lot # M028323; expiration date 26-SEP-2018; and lot # L037554, expiration date 25-DEC-2017 (dose and route of administration were not reported) for prophylaxis, which were exposed to temperature excursion, a total time in the range of 47° Fahrenheit (F) to 77°F (48F), for a time frame of 8 hours. There was a previous temperature excursion, the total time in the range 47°F to 77°F (55F) for 8 hours. There was no data logger. No adverse effects reported. No product quality complaint was involved. This is one of the several reports from the same reporter. Additional information has been requested. Sender's Comments: US-009507513-1703USA013155: US-009507513-1703USA013740: US-009507513-1703USA013741: US-009507513-1703USA013742.
.Extreme pain in the left shoulder, with stiffness in the joint, unable to move anywhere.  The pain began at the time of vaccination and the pain increased each day, with the maximum bearable pain being on day 7 after vaccination.  I went to the hospital on April 26th where I received care and then went to the orthopedist April 27th
The night of the shot maybe around 2 am or so the left bottom portion of my nose started burning and went numb. Feeling returned and when I woke back up around 8 am the Left side of my face was numb mostly my Left cheek, lips, part of my nose, occasionally eyebrow. I went to the ER which just prescribed steroids and said take them if my face gets worse. I did not take the medication and my face started to feel less numb and was almost back to normal after 4 days. I also had pain my left arm for about that long as well which is too be expected from the shot. My feet started to tingle around day 3. It then progressed up my legs and to my hands as well. Around day 5 I started having electric shocks all over my body including my tongue, private regions, back, but mostly focusing in the legs (mostly feet) and hands. It has now been almost a week and a half and my top lip on the left side feels a little odd/numb/dropping feeling and I get pain in my left cheek near my tempel bone at times. Today my R arm started tremoring when I pressed it against my forehead. It happened three times in a row before it stopped. I have an appointment with a neurogist tom and I am hoping to get some answers. I already have an autoimmune disease and I am hoping this shot did not set off another one or cause permanent damage. I believe in vaccines and am just sad.
This spontaneous case was reported by a nurse and describes the occurrence of VACCINATION SITE MOVEMENT IMPAIRMENT (injected arm was minimally sore especially when reaching over her head), VACCINATION SITE PAIN (injected arm was minimally sore especially when reaching over her head) and COVID-19 (got Covid in April of 2022) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 039F21A, 044A21A and 006M20A) for COVID-19 vaccination. No Medical History information was reported. On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 17-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In April 2022, the patient experienced COVID-19 (got Covid in April of 2022). On an unknown date, the patient experienced VACCINATION SITE MOVEMENT IMPAIRMENT (injected arm was minimally sore especially when reaching over her head) and VACCINATION SITE PAIN (injected arm was minimally sore especially when reaching over her head). At the time of the report, VACCINATION SITE MOVEMENT IMPAIRMENT (injected arm was minimally sore especially when reaching over her head), VACCINATION SITE PAIN (injected arm was minimally sore especially when reaching over her head) and COVID-19 (got Covid in April of 2022) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In April 2022, SARS-CoV-2 test: (Positive) Positive. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medication was reported. No treatment medication was reported. Company comment: This is a spontaneous case concerning a 71 years old female, with no medical history, who experienced unexpected non serious AESI events of covid-19, which occurred approximately 5 months after third dose of mRNA-1273 vaccine. SARS-CoV-2 test Positive approximately 5 months after third dose of mRNA-1273 vaccine. At the time of report outcome of the events is unknown. Current ongoing pandemia remains as confounder. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report. This case was linked to MOD-2022-630782, MOD-2022-630787 (Patient Link). Sender's Comments: This is a spontaneous case concerning a 71 years old female, with no medical history, who experienced unexpected non serious AESI events of covid-19, which occurred approximately 5 months after third dose of mRNA-1273 vaccine. SARS-CoV-2 test Positive approximately 5 months after third dose of mRNA-1273 vaccine. At the time of report outcome of the events is unknown. Current ongoing pandemia remains as confounder. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.
vaccine from punctured vial that was on the counter since 16Jul21 and administered on 30Jul2021/Invalid dose; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (vaccine from punctured vial that was on the counter since 16Jul21 and administered on 30Jul2021/Invalid dose) in a 35-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025C21A) for COVID-19 vaccination.     No relevant medical history or concomitant medication.     On 30-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Jul-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (vaccine from punctured vial that was on the counter since 16Jul21 and administered on 30Jul2021/Invalid dose). On 30-Jul-2021, EXPIRED PRODUCT ADMINISTERED (vaccine from punctured vial that was on the counter since 16Jul21 and administered on 30Jul2021/Invalid dose) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment details were reported.
An 11 year old patient was accidentally administered an adult dose of Pfizer as his second dose.
About 5 minutes after receiving the Meningococcal and HPV vaccines injected into his left arm, and the Flu vaccine administered nasally, he began having a reaction. He was standing beside me as I was sitting in a chair at the desk making his follow-up appointment, when he knelt down, put his head down, and said his ears were ringing. He then said his vision was "funny, kinda like tunnel vision". As a RN myself, I knew he could possibly be close to fainting, so I had him immediately sit in the chair beside me. I noticed he started to sweat profusely on his forehead, so the receptionist went to get him a cold, wet towel and I put it on the back of his neck. The office's Social Worker happened to be there at the front desk, so she went to get him some apple juice. I had my son put his head down and lean forward a bit, to get blood flowing to is brain. He was extremely pale so I also asked for the Medical Assistant to check his blood pressure, which was very low at 100/49 (it had been 122/78 at the beginning of his appointment around 9:15 AM). Someone brought him a package of goldfish crackers, and some water (because he had drank all of the apple juice). After about 10 minutes, he appeared much better, his color came back and the ringing in his ears along with the tunnel vision had gone away. He said "I feel much better". I took him home and checked his blood pressure, which was 138/82. I then had him eat/drink a little and rest for the remainder of the day. He was supposed to return to school after his appointment, but I thought it best to keep him home.
12 hours after vaccine she began to run low grade fever for 2 days and slept most of the day and n ight,  third day she woke up and seemed fine but Day 4 when she got up she was crying her mouth hurt and when i looked her tongue seemed yellowish and the roof of her mouth and around her gums had this yellowish ulcerated look.  She could not eat and it was very painful.  I took her to local urgent Care and the provider told me it was a reaction to the vaccine .  She prescribed magic mouthwash but i could not find a pharmacy to fill it as it was a compound, so i gave her tyelenol for pain and had her rinse her mouth with a medicated mouthwash.  after three days she felt better.
rash on his thigh (injection site); has been really irritable; received Proquad and Varivax accidently; This spontaneous report was received from a patient's mother and refers to her son, 12-month-old male patient. No information regarding patient's pertinent medical history, drug reactions, allergies and concomitant medications.   On 21-OCT-2021, the patient was accidently vaccinated with his first doses of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) and varicella virus vaccine live (oka/merck)(VARIVAX) both in left thigh for prophylaxis (reported as routine vaccination) (exact doses, routes, lot # and expiration dates were not provided).  On the same date, he developed rash on his thigh (injection site) and had been really irritable. He received ibuprofen (MOTRIN) and tylenol as a treatment. He had not any laboratory diagnostic done. The outcome of the events was reported as not resolved.   The causality assessement was not provided.
pt recv vax 9MAY97 & 16MAY97 pt devel a non-pruritic maculo-papular rash on head & trunk & fever f 103;19MAY97 pt presented to MD office;
Patient presented with pleuritic chest pain and exertional SOB for 3-4 days. CT angio of chest revealed subsegmental PE RLL. Patient was stable and discharged home on oral anticoagulant.
Patient reported adverse event on 9/1/2018. Received vaccine on 8/29/2018 around 5 pm and around 8pm felt like she had low grade fever, redness/itching at injection site, and felt very tired. 2 days later she had a small earache (unsure if related). On 9/1/2018, symptoms resolved except for redness/itching at injection site.
2nd dose of vaccine was given prior to recommended date (day 16 vs day 21).
Complex febrile seizure - fever 103.9 degrees on morning after received DTaP, had multiple prolonged generalized tonic-clonic seizures over 1-2 hrs. EMS to hospital, PICU admit. CT head (-) CSF cx (-).
States around 5:00 PM she noted her arm was sore at the injection site and her arm was hurting below the elbow. The pain worsened and spread to the palm of her hand and wrist. Around 3:00 AM, Friday morning, the pain became worse, waking her up. Pain continued from the elbow down into the hand, wrist area, was unable to bend her arm, no strength or grip in the hand. If she placed her hand flat on a table, she experienced excruciating pain in the palm of her hand and fingers. Following this, she experienced tingling between her fingers. Friday morning she contacted her family physician, described her symptoms and he stated he stated he believed a nerve had been hit during the injection process, instructed her to go to an urgent care for an X-ray to rule out a fracture. Client went to urgent care. X-ray was performed, negative for fracture. Physician provided same diagnosis as family physician, Radical Nerve (unsure of last word). Prescribed Prednisone and Neurontin. Was instructed to stop Prednisone when symptoms improved. Client state she took Prednisone Friday - Sunday, and stopped on Monday, December 3. Continues Neurontin, takes AM and PM. Pain is greatly improved, continues to have sore palm of wrist. Recovering but not fully recovered.
Rash all over body, on trunk, palms, legs; denies breathing difficulty or throat/tongue swelling Treatment: Depo-Medrol : 1.5 mL (Dose No:1) (Route: Intramuscular) given on left buttock
Day following administration of Prevnar 13, parents called me when I was on call because patient did not want to bear weight on leg, shot was given in
Chills; Not feeling good at all; Achiness; Back pain; Stomach cramps; Felt terrible; It was a slight fever 99; cannot sleep; This is a spontaneous report from a contactable consumer. An 85-year-old female patient received her second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 10Feb2021 12:00 (Batch/Lot number was not reported) as SINGLE DOSE for covid-19 immunisation. Medical history included diabetic. Concomitant medications were reported but was unspecified (patient stated that she have too many of them). The patient received her first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 23Jan2021 for covid-19 immunisation (85 years old). The patient experienced chills on 10Feb2021 22:00, not feeling good at all, achiness, back pain, stomach cramps, felt terrible, it was a slight fever 99 and cannot sleep on 10Feb2021. The patient underwent lab tests and procedures which included blood work: have a lot of blood work. Every 6 months she had to have my blood taken. Because of the pandemic she have not been going to doctor and body temperature: it was a slight fever 99 on an unspecified date. Therapeutic measures were taken as a result of fever included Tylenol. Outcome of the events was recovering.   Information on the lot/batch number has been requested.
9/26/03-Erythem, swelling around injection site to elbow area.  Approximately 6 inches long by 2 inches wide. 9/27/03 ER-seen by physician.  Pt. on Keflex x10 days.
The patient woke up the next morning with a rash on her tongue and congestion or swelling in the back of her throat. She reports she took one OTC Benadryl and with in 4 hours all the symptoms were gone.